In SLE, lncRNA-NEAT1 targets the JAK-STAT signaling pathway by binding to miR-365a-3p, thereby inhibiting its promotion of IL-6 secretion, which helps to improve SLE symptoms. Here, IL6 is linked to systemic lupus erythematosus.